PRL and rheumatoid arthritis: PRL induces the phosphorylation/activation of STAT3 in cultured in synovial fibroblasts to inhibit Cyt-induced expression of IL-1β, IL-6, and receptor activator of nuclear factor κB ligand (RANKL), a major promoter of osteoclastogenesis in RA (43) (Figure 1).